PURCHASE AGREEMENT
This
Purchase Agreement
(this "AGREEMENT") is dated as of April
4, 2005
among Calypte Biomedical Corporation, a Delaware corporation (the "COMPANY"),
and the investors identified on the signature
pages hereto (each an
"INVESTOR"
and, collectively, the "INVESTORS").
WHEREAS,
subject to the terms
and conditions set forth in this Agreement,
the Company desires to borrow certain sums from each of the
Investors and, in
consideration thereof issue certain convertible notes and warrants to each of
the Investors, and each Investor, severally and not jointly, desires
to make a
loan to the Company and accept such notes
and warrants
from the Company, all
pursuant to the terms set forth herein.
NOW,
THEREFORE, IN CONSIDERATION of the mutual covenants contained in
this
Agreement, and for other good and valuable consideration the receipt and
adequacy of which are hereby acknowledged, the Company and the Investors
agree
as follows:
ARTICLE I.
DEFINITIONS
1.1
Definitions.
In addition to the terms defined elsewhere in this
Agreement, for all purposes of this
Agreement,
the following terms
shall have
the meanings indicated in this Section
1.1:
"ACTION" means any
action, suit, inquiry, notice of violation,
proceeding (including any partial proceeding such as a deposition) or
investigation pending or threatened in
writing against or affecting the Company,
any Subsidiary or any of their
respective
properties
before or by any
court,
arbitrator, governmental or administrative agency, regulatory authority
(federal, state, county, local or foreign), stock market, stock exchange or
trading facility.
"ADDITIONAL WARRANT" means the Common Stock purchase warrant, in
the
form of Exhibit D, issuable to each
Investor at the Closing.
"AFFILIATE" means any
Person that, directly
or indirectly
through
one or more intermediaries, controls or is controlled by or is under common
control with a Person, as such terms are
used in and construed under Rule 144.
"BANKRUPTCY EVENT"
means any of the following events: (a) the
Company or any Subsidiary commences a proceeding under any bankruptcy,
reorganization, arrangement, adjustment of
debt, relief of debtors, dissolution,
insolvency or liquidation or similar law of any jurisdiction relating to the
Company or any Subsidiary thereof; (b)
there is commenced against the Company or
any Subsidiary any such case or proceeding
that is not dismissed
within 60 days
after commencement; (c) the Company or any Subsidiary
is adjudicated by a court
of competent jurisdiction insolvent or bankrupt
or any order of relief or other
order approving any such case or
proceeding is entered;
(d) the Company or any
Subsidiary suffers any appointment of any custodian or the like for
it or any
substantial part of its property that is
not discharged or stayed within 60
<PAGE>
days; (e) under applicable law the Company or any
Subsidiary
makes a general
assignment for the benefit of creditors;
(f) the Company or any Subsidiary fails
to pay, or states that it is unable to pay or is unable to pay, its debts
generally as they become due; (g) the
Company or any Subsidiary calls a meeting
of its creditors with a view to arranging a composition, adjustment or
restructuring of its debts; or (h) the
Company or any Subsidiary, by any act or
failure to act, expressly indicates its consent to, approval
of or acquiescence
in any of the foregoing or takes any
corporate or other
action for the purpose
of effecting any of the foregoing.
"BASIC AMOUNT" shall have the meaning set forth in Section 4.4.
"BENEFIT ARRANGEMENT"
means at any time an
employee benefit
plan
within the meaning of Section 3(3) of ERISA
which is not a Plan or Multiemployer
Plan and which is maintained or otherwise
contributed by the Company.
"BENEFIT PLAN" has the meaning set forth in Section
3.1(aa)(ii).
"BUSINESS DAY"
means any day except
Saturday, Sunday and any day
that is a federal legal holiday or a day on
which banking
institutions
in the
State of New York are authorized or
required by law or other governmental action
to close.
"CLOSING" means the
closing of the
purchase and sale of
Notes and
Warrants contemplated by Section 2.1.
"CLOSING DATE" means the Business Day immediately following the
date
on which all of the conditions set forth in Section
2.1(d) and 2.1(e) have been
satisfied, or such other date as the
parties may agree.
"CODE" means the Internal Revenue Code of 1986, as amended.
"COMMISSION" means the Securities and Exchange Commission.
"COMMON STOCK" means the common stock of the Company, par value
$.03
per share, and any securities into which such common
stock may hereafter be
reclassified, converted or exchanged.
"COMMON STOCK
EQUIVALENTS" means any
securities of the
Company or
any Subsidiary which entitle the holder thereof
to acquire Common Stock at any
time, including without limitation,
any debt, preferred
stock, rights, options,
warrants or other instrument that is at any time convertible into or
exchangeable for, or otherwise entitles the holder thereof to
receive, Common
Stock or other securities that entitle the holder to receive, directly or
indirectly, Common Stock.
"COMPANY COUNSEL" means Coudert Brothers LLP.
2
<PAGE>
"DEBT" of any Person means at any date, without duplication, (i)
all
obligations of such Person for borrowed
money, (ii) all obligations of such
Person evidenced by bonds, debentures, notes, or other similar instruments
issued by such Person, (iii) all obligations of such Person in respect of
the
deferred purchase price of property or
services (including
contingent
payment,
earn-out and similar obligations but
excluding current accounts payable incurred
in the ordinary course of business), (iv) all obligations of such Person as
lessee which (y) are capitalized in accordance
with GAAP or (z) arise
pursuant
to sale-leaseback transactions, (v) all
reimbursement obligations of such Person
in respect of letters of credit or other similar instruments, (vi) all
obligations, contingent or otherwise, of such Person in respect of bankers'
acceptances, (vii) obligations of such Person
to pay a specified purchase price
for goods or services whether or not delivered or
accepted (e.g.,
take or pay
obligations) or similar obligations, (viii) all obligations and
liabilities of
others of the foregoing types
("indebtedness") secured by a Lien on any asset of
such Person, whether or not such Debt is
otherwise an obligation of such Person,
and (ix) any obligation, contingent or
otherwise, of such Person guaranteeing or
having the economic effect of guaranteeing or agreeing to pay or become
responsible for any indebtedness of any other Person in any manner, whether
directly or indirectly, including without limitation any obligation of such
Person, direct or indirect, (a) to purchase or pay (or advance
or supply funds
for the purchase or payment of) such
indebtedness or to
purchase (or to advance
or supply funds for the purchase of) any security for the payment of such
indebtedness, (b) to purchase property or services for the
purpose of assuring
the owner of such indebtedness of its
payment, or (c) to
maintain the solvency,
working capital, equity, cash flow, fixed
charge or other coverage ratio, or any
other financial condition of the primary obligor so as to enable the
primary
obligor to pay any indebtedness or to
comply with any agreement relating to any
indebtedness or obligation, provided that the term
"indebtedness"
shall not
include endorsements for collection or deposit in the ordinary course of
business. The Debt of any Person
shall include the Debt of any other entity
(including any partnership in which such Person is a general
partner) to the
extent such Person is liable therefor as a result of such Person's ownership
interest in or other relationship with such entity, except to the extent the
terms of such Debt expressly provide that
such Person is not liable therefor.
"DISCLOSURE MATERIALS" has the meaning set forth in Section
3.1(h).
"EFFECTIVE DATE"
means the date that the Registration Statement
required by Section 2(a) of the
Registration Rights
Agreement is first declared
effective by the Commission.
"ELIGIBLE MARKET" means any of the New York Stock Exchange,
American
Stock Exchange, NASDAQ National Market or
NASDAQ SmallCap Market.
"ERISA" means the Employee Retirement Income Security Act of 1974,
as amended, or any successor statute.
"ERISA GROUP" means the Company and each Subsidiary and all members
of a controlled group of corporations
and all trades or
businesses (whether
or
not incorporated) under common control which,
together with the
Company or any
Subsidiary, are treated as a single
employer under the Code.
3
<PAGE>
"EXCHANGE ACT"
means the Securities Exchange Act of 1934, as
amended.
"GAAP" means U.S. generally accepted accounting principles.
"INITIAL WARRANT"
means the Common Stock purchase warrant, in the
form of Exhibit C, issuable to each
Investor at the Closing.
"INTELLECTUAL PROPERTY
RIGHTS" has the meaning set forth in Section
3.1(p).
"INVESTMENT AMOUNT"
means, with respect to each Investor, the
investment amount indicated below such
Investor's signature to this Agreement.
"INVESTOR DELIVERABLES" has the meaning set forth in Section
2.1(c).
"INVESTOR PARTY" has the meaning set forth in Section 4.12.
"LIEN" means any lien, charge, encumbrance, security interest,
right
of first refusal or other restrictions of
any kind.
"LOSSES" has the meaning set forth in Section 4.12.
"MATERIAL ADVERSE
EFFECT" means any of (i) a material and
adverse
effect on the legality, validity or enforceability of any
Transaction Document,
(ii) a material and adverse effect on the results of operations, assets,
prospects, business or condition (financial
or otherwise) of the Company and the
Subsidiaries or (iii) an adverse
impairment to the
Company's ability to
timely
perform its obligations under any
Transaction Document.
"NEW YORK COURTS" means the state and federal courts sitting in the
City of New York, Borough of Manhattan.
"NOTES" means the secured convertible promissory notes issuable by
the Company to the Investors at Closing in the Form of Exhibit
A, due on the
three year anniversary of the Closing
Date.
"NOTICE OF ACCEPTANCE"
shall have the meaning
set forth in Section
4.4.
"OFFER" shall have the meaning set forth in Section 4.4.
"OFFERED SECURITIES"
shall have the
meaning set forth in Section
4.4.
"OUTSIDE DATE" means April 6, 2005.
"PBGC" means the Pension Benefit Guarantee Corporation or any
entity
succeeding to any or all of its functions
under ERISA.
4
<PAGE>
"PERMITTED FOREIGN
SUBSIDIARY
DEBT" means Debt of all foreign
Subsidiaries and guarantees by the Company of such Debt, in an aggregate
principal amount (without duplication) not to exceed $5,000,000 at any time
outstanding.
"PERMITTED
INDEBTEDNESS" means:
(a) Debt in existence
on the date
hereof, as shown on Schedule 5.3,
including any
extensions or renewals thereof,
provided, there is no increase in the principal amount thereof or other
significant change in the terms thereof,
(b) trade payables incurred and paid in
the ordinary course of business,
(c) the Vencore
Purchase Money Financing, (d)
Debt of the Company incurred to finance the
purchase of equipment or other
personal property, which is secured by the property
being purchased
(including
obligations of the Company as lessee which
are capitalized
in accordance
with
GAAP or arise pursuant to sale-leaseback
transactions) in an aggregate principal
amount not to exceed $3,000,000 at any time outstanding
(excluding the
Vencore
Purchase Money Financing), provided that such Debt is
incurred promptly
after
the acquisition of such equipment or
personal property,
but in no event
later
than 90 days thereafter, (e) unsecured Debt of the Company
in connection with
transactions involving acquisitions,
equipment or real property leases, sale and
leasebacks, strategic partnering, or licensing
arrangements, provided
that (i)
the aggregate principal amount of such Debt
shall not exceed
$3,000,000 at any
time outstanding and (ii) such Debt is
subordinated to the Obligations pursuant
to subordination agreements in form and substance
acceptable to the
Investors,
(f) unsecured Debt of the Company incurred in connection with any financing
arrangement with Marr Technologies BV in an aggregate
principal amount not
to
exceed $5,500,000 at any time outstanding and (g) the Permitted Foreign
Subsidiary Debt.
"PERMITTED LIENS"
means: (a) Liens for taxes, assessments or
governmental charges not delinquent or being contested in good faith and by
appropriate proceedings and for which adequate
reserves in accordance with GAAP
are maintained on the books of the
Company or the
applicable Subsidiary;
(b)
Liens arising out of deposits in connection with workers' compensation,
unemployment insurance, old age pensions,
social security or retirement benefits
legislation incurred in the ordinary course
of business; (c) deposits or pledges
to secure bids, tenders, contracts (other than contracts for the payment of
money), leases, statutory obligations, surety and appeal bonds, and other
obligations of like nature arising in the ordinary course of business of the
Company or a Subsidiary; (d) Liens imposed
by law, such as mechanics', workers',
materialmens', carriers' or other like liens
arising in the ordinary course of
business of the Company or a Subsidiary
which secure the
payment of obligations
which are not past due or which are being
diligently contested
in good faith by
appropriate proceedings and for which adequate
reserves in accordance with GAAP
are maintained on the books of the
Company or the
applicable Subsidiary;
(e)
Liens existing on the date hereof and
specified on Schedule
3.1(dd), provided
that each such Lien does not apply to other
property or asset of
the Company or
any Subsidiary and such Lien shall secure
only those obligations
its secures on
the date hereof (including any extensions or renewals thereof that do not
increase in the principal amount thereof); (f) Liens on the assets of
foreign
Subsidiaries securing Permitted Foreign
Subsidiary Debt, (g) Liens of commercial
depository institutions, arising in the ordinary course of business,
constituting a statutory or common law right of setoff against amounts on
deposit with such institution; (h) rights
of way, zoning restrictions, easements
and similar encumbrances affecting the Company's real property which do not
materially interfere with the use of such property; (i) Liens on fixed or
5
<PAGE>
capital assets acquired by the Company,
provided that (1) such
Lien secures in
connection with Debt described in clause (c) or (d) of the definition of
Permitted Indebtedness, (2) such Lien and the Debt secured
thereby are incurred
within 90 days after such acquisition, (3) the Debt secured thereby does not
exceed the cost of acquiring such assets and (4) such Lien shall not
apply to
any other assets or property of the
Company or any
Subsidiary;
and (j) Liens
created under the Security Agreement.
"PERSON" means an
individual or
corporation,
partnership,
trust,
incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or
subdivision thereof)
or other entity of any kind.
"PLAN" means at any time an employee pension plan benefit plan
which
is covered by Title IV of ERISA or
subject to the
minimum funding standards
under the Code and either (i) is
maintained, or contributed to, by any member of
the ERISA group for employees of any member of the ERISA group
or (ii) has at
any time within the preceding five years
been maintained, or
contributed to, by
any Person which was at such time a member of
the ERISA Group for
employees of
any Person which was at such time a member
of the ERISA group.
"PRIOR PLACEMENTS" means that certain Securities Purchase
Agreement,
dated May 28, 2004, and that certain
Securities Purchase
Agreement, dated
July
9, 2004, as each have been amended pursuant to that certain Amendment to
Securities Purchase Agreement, dated as of
the date hereof ("AMENDMENT").
"PROCEEDING" means
an action, claim, suit, investigation or
proceeding (including, without limitation, an investigation or partial
proceeding, such as a deposition), whether
commenced or threatened.
"REFUSED SECURITIES"
shall have the
meaning set forth in Section
4.4.
"REGISTRATION
STATEMENT" means a registration statement meeting the
requirements set forth in the Registration Rights Agreement and covering the
resale by the Investors of the Underlying
Shares and Warrant Shares.
"REGISTRATION
RIGHTS AGREEMENT"
means the Registration Rights
Agreement, dated as of the date of this
Agreement,
among the Company and the
Investors, in the form of Exhibit B
hereto.
"REQUIRED INVESTORS"
means one or more Investors representing
greater than 50% of the aggregate principal amount of all Notes then
outstanding.
"REQUIRED MINIMUM"
means, as of any date, the maximum aggregate
number of shares of Common Stock then issued or potentially issuable in the
future pursuant to the Transaction Documents that the Company is
obligated to
issue, whether contingently or otherwise,
including,
without limitation,
any
Underlying Shares issuable upon conversion in full of all Notes and
Warrant
Shares issuable upon exercise in full of all
Warrants (without
regard to any
otherwise applicable conversion or exercise
restrictions
contained therein)
(assuming for such purpose that the
Conversion
Price (as defined in
the Notes)
and the Exercise Price (as defined in the
Warrants) equals 75% of the Conversion
Price and Exercise Price in effect on the
Closing Date).
6
<PAGE>
"RESTRICTED PAYMENT"
means, with respect to any Person,
(a) any
direct or indirect distribution, dividend or other payment (whether in cash,
securities or other property) on account of
any equity interest in, or shares of
capital stock or other securities of, such Person,
(b) any payment
(whether in
cash, securities or other property), including any sinking fund or similar
deposit, on account of the purchase, redemption, retirement, acquisition,
cancellation or termination of any such equity interest, (c) any payment of
principal or interest or any purchase,
redemption,
retirement,
acquisition or
defeasance with respect to any Debt of such
Person which is subordinated to the
payment of the Notes, unless such payment
is expressly permitted by the terms of
the applicable subordination agreement, (d) other than as
permitted by Section
5.10, the acquisition for value by such Person of any
Debt or equity
interest
issued by any Affiliate (other than a
wholly-owned
subsidiary) thereof, and (e)
any management, consulting or other similar fees, or any interest thereon,
payable by such Person to any Affiliate of
such Person (other than the Company),
or to any other Person other than an
unrelated third party;
provided, however,
that Restricted Payments shall not include
payments under consulting agreements
so long as such consulting agreements which contain equity
components have been
approved by the Board of Directors of the
Company.
"RULE 144" means Rule 144 promulgated by the Commission
pursuant to
the Securities Act, as such Rule may be amended from time to time, or any
similar rule or regulation hereafter adopted by the Commission having
substantially the same effect as such
Rule.
"SEC REPORTS" has the meaning set forth in Section 3.1(h).
"SECURITIES" means the
Notes, the Warrants,
the Underlying
Shares
and the Warrant Shares.
"SECURITIES ACT" means the Securities Act of 1933, as amended.
"SECURITY AGREEMENT" has the meaning set forth in Section
2.1(b).
"SHORT SALES"
include, without limitation, all "short sales" as
defined in Rule 3b-3 of the Exchange Act and Rule 200 promulgated under
Regulation SHO under the Exchange Act and
all types of direct and indirect stock
pledges, forward sale contracts,
options, puts, calls, short sales, swaps
and
similar arrangements (including on a total return
basis), and sales and
other
transactions through non-US broker dealers
or foreign regulated brokers.
"STRATEGIC TRANSACTION" means a transaction or relationship in
which
the Company issues shares of Common Stock
or other securities of
the Company to
a Person which is, itself or through its
subsidiaries, an operating company in a
business synergistic with the business of the Company
and in which the Company
receives benefits in addition to the
investment of funds, but shall not include
a transaction in which the Company is issuing securities primarily for the
purpose of raising capital or to an entity whose
primary business is
investing
in securities. Strategic Transaction includes bona fide equipment or real
property leases, sale and leaseback, or
licensing agreements, provided that such
transaction is approved by the Board of
Directors of the company and is not for
the purpose of raising capital.
7
<PAGE>
"SUBSEQUENT PLACEMENT"
shall have the meaning
set forth in Section
4.4.
"SUBSIDIARY" means any
subsidiary
of the Company now or
hereafter
existing in which the Company, directly or indirectly, owns a majority of the
voting stock or other voting equity
interests.
"TRADING DAY" means (i) a day on which the Common Stock is traded
on
an Eligible Market, or (ii) if the Common Stock is not listed on an
Eligible
Market, a day on which the Common Stock is traded in the over-the-counter
market, as reported by the OTC Bulletin
Board or the National
Quotation Bureau
Incorporated, or (iii) if the Common
Stock is not
quoted on the OTC
Bulletin
Board, a day on which the Common Stock is
quoted in the over-the-counter market
as reported by the National Quotation Bureau Incorporated (or any similar
organization or agency succeeding to its functions of reporting prices);
provided, that in the event that the Common
Stock is not listed or quoted as set
forth in (i), (ii) and (iii) hereof, then
Trading Day shall mean a Business Day.
"TRADING MARKET" means whichever of the New York Stock Exchange,
the
American Stock Exchange, the NASDAQ National Market, the
NASDAQ SmallCap Market
or OTC Bulletin Board on which the Common Stock is
listed or quoted for trading
on the date in question.
"TRANSACTION
DOCUMENTS" means
this Agreement, the Notes, the
Registration Rights Agreement, the Warrants, the Security Agreement, the
Amendment, the Voting Agreement and any other
documents or agreements executed
in connection with the transactions
contemplated hereunder.
"UNDERLYING SHARES"
means the shares of Common Stock issuable upon
conversion of the Notes and payment of
interest thereunder.
"VENCORE PURCHASE
MONEY FINANCING" means Debt of the Company
incurred in connection with the Vencore equipment financing line (whether
pursuant to a loan, capital lease obligation, sale/leaseback transaction or
otherwise) in an aggregate principal amount not to exceed one million
dollars
($1,000,000) at any time outstanding,
provided that such Debt is incurred within
90 days after such acquisition of such
equipment.
"VOTING AGREEMENT" means that certain voting agreement, by and
among
the Company and the stockholders identified therein, dated as of the date
hereof.
"VWAP" means, with respect to any date of determination, the daily
volume weighted average price (as reported by
Bloomberg using the VAP function)
of the Common Stock on such date of
determination, or if
there is no such price
on such date of determination, then the daily volume weighted
average price on
the date nearest preceding such date.
8
<PAGE>
"WARRANTS" means,
collectively,
the Initial Warrants and the
Additional Warrants.
"WARRANT SHARES"
means the shares of
Common Stock
issuable upon
exercise of the Warrants.
ARTICLE II.
PURCHASE AND SALE
2.1
Closing.
(a) Subject to the terms and conditions set forth in this
Agreement,
at the Closing the Company shall issue and sell to each
Investor, and each
Investor shall, severally and not jointly,
purchase from the
Company, the Notes
and the Warrants representing such Investor's
Investment
Amount. The Closing
shall take place at the offices of Bryan
Cave LLP, 1290 Avenue
of the Americas,
New York, NY 10104 at 4:30 p.m. (New York City time) on the
Closing Date or at
such other location or time as the parties
may agree.
(b) At the Closing,
the Company shall deliver or cause to be
delivered to each Investor the following
(the "COMPANY DELIVERABLES"):
(i) Notes in the aggregate principal amount of the
Investment
Amount indicated below such Investor's name on its signature page of this
Agreement, registered in the name of such
Investor;
(ii) Initial
Warrants, registered in the name of such
Investor, pursuant to which such
Investor shall have the right to acquire
the
number of shares of Common Stock equal to
100% of the Underlying Shares issuable
upon an assumed conversion of the Notes issuable
to such Investor in accordance
with Section 2.1(b)(i) (without regard to
any conversion
restrictions contained
thereunder);
(iii) Additional
Warrants, registered in the name of such
Investor, pursuant to which such
Investor shall have the right to acquire
the
number of shares of Common Stock equal to
45% of the Underlying
Shares issuable
upon an assumed conversion of the Notes issuable
to such Investor in accordance
with Section 2.1(b)(i) (without regard to
any conversion
restrictions contained
thereunder);
(iv) the legal opinion
of Company Counsel,
in agreed form,
addressed to the Investors;
(v) the Registration
Rights Agreement,
duly executed by
the
Company;
(vi) a security
agreement, duly
executed by the Company, in
the form attached hereto as Exhibit D (as amended,
supplemented
or otherwise
modified from time to time, the "SECURITY
AGREEMENT");
9
<PAGE>
(vii) a certificate
executed by a duly authorized officer of
the Company certifying that (i) all
representations
and warranties made by
the
Company and information furnished by the Company in any schedules to this
Agreement, are true and correct in all
material respects as of the Closing Date,
(ii) all covenants, agreements and obligations
required by this Agreement to be
performed or complied with by the Company,
prior to or at the Closing, have been
performed or complied with and (iii) the items referenced in Sections
2.1(d)(iv)-(vi) are true and correct as of
the Closing Date;
(viii) lien and record
search reports in form
and substance
acceptable to the Investors showing that there are no Liens on
the collateral
security granted under the Security Agreement, other than Liens expressly
permitted thereby; and
(ix) any other documents reasonably requested by such
Investor.
(c) At the Closing,
each Investor shall deliver or cause to be
delivered to the Company the following (the
"INVESTOR DELIVERABLES"):
(i) the Investment Amount indicated below such Investor's name
on its signature page of this Agreement, in United States dollars and in
immediately available funds, by wire transfer to an account designated in
writing by the Company for such
purpose;
(ii) the Registration Rights Agreement, duly executed by such
Investor; and
(iii) the Security Agreement, duly executed by such Investor.
(d) Conditions
Precedent to the Obligations of an Investor to
Purchase Notes and Warrants. The obligation of each Investor to
acquire Notes
and Warrants and make loans at the Closing is
subject to the
satisfaction or
waiver by such Investor, at or before the Closing, of each of the following
conditions:
(i) Representations
and Warranties.
The representations
and
warranties of the Company contained in the Transaction
Documents shall be
true
and correct as of the date when made and as
of the Closing
Date as though
made
on and as of such date;
(ii) Performance. The Company shall have performed, satisfied
and complied with all covenants, agreements and conditions required by the
Transaction Documents to be performed, satisfied or complied with by it
at or
prior to the Closing;
(iii) Officer's
Certificate.
The officer's certificate
described in Section 2.1(b)(vii) hereof
shall have been delivered;
(iv) No Injunction. No
statute, rule,
regulation,
executive
order, decree, ruling or injunction shall have been enacted, entered,
promulgated or endorsed by any court or
governmental
authority of competent
jurisdiction that prohibits the consummation of any of the transactions
contemplated by the Transaction
Documents;
10
<PAGE>
(v) Adverse Changes. Since the execution of this Agreement, no
event or series of events shall have
occurred that has had
or would
reasonably
be expected to result in a Material Adverse
Effect;
(vi) No
Suspensions
of Trading in Common Stock; Listing.
Trading in the Common Stock shall not have
been suspended by the
Commission or
any Trading Market (except for any suspensions of trading of not more
than one
Trading Day solely to permit dissemination
of material information regarding the
Company) at any time since the date of
execution of this Agreement, and the
Common Stock shall have been at all times
since such date listed for trading on
an Eligible Market; and
(vii) Company
Deliverables. The
Company shall have delivered
the Closing Company Deliverables in
accordance with Section 2.1(b).
(e) Conditions
Precedent to the Obligations of the Company to
sell Notes and Warrants. The obligation of the Company to sell Notes and
Warrants at the Closing is subject to the
satisfaction or waiver by the Company,
at or before the Closing, of each of the
following conditions:
(i) Representations
and Warranties.
The representations
and
warranties of each Investor contained
herein shall be true and correct as of the
date when made and as of the Closing Date
as though made on and as of such date;
(ii)
Performance.
Each Investor
shall have performed,
satisfied and complied in all material
respects with all
covenants,
agreements
and conditions required by the Transaction
Documents to be performed, satisfied
or complied with by such Investor at or
prior to the Closing;
(iii) No Injunction.
No statute, rule, regulation, executive
order, decree, ruling or injunction shall have been enacted, entered,
promulgated or endorsed by any court or
governmental
authority of competent
jurisdiction that prohibits the consummation of any of the transactions
contemplated by the Transaction Documents;
and
(iv) Investors
Deliverables.
Each
Investor shall have
delivered its Investor Deliverables in
accordance with Section 2.1(c).
(f) American Stock
Exchange Approval.
The American Stock
Exchange
shall have orally approved the American Stock Exchange Additional Listing
Application submitted by the Company (in a
form acceptable
to the Investors)
with respect to the transactions
contemplated by the Transaction Documents.
ARTICLE III.
REPRESENTATIONS AND WARRANTIES
3.1
Representations
and Warranties of the Company.
The Company
hereby
makes the following representations and
warranties to each Investor:
11
<PAGE>
(a) Subsidiaries. The Company has no direct or indirect
Subsidiaries
other than as specified in the SEC Reports. Except as disclosed in Schedule
3.1(a), the Company owns, directly or indirectly,
all of the capital
stock of
each Subsidiary free and clear of any and all Liens (other than Permitted
Liens), and all the issued and outstanding shares of capital stock of each
Subsidiary are validly issued and are fully paid,
non-assessable
and free of
preemptive and similar rights.
(b) Organization and Qualification. The Company and each
Subsidiary
are duly incorporated or otherwise organized, validly existing and in good
standing under the laws of the jurisdiction
of its incorporation or organization
(as applicable), with the requisite power and authority to own and use its
properties and assets and to carry on its
business as currently conducted.
Neither the Company nor any Subsidiary is in violation of any
of the provisions
of its respective certificate or articles of incorporation, bylaws or other
organizational or charter documents. The Company and each Subsidiary
are duly
qualified to conduct its respective businesses and are in good standing as a
foreign corporation or other entity in
each jurisdiction in which the nature of
the business conducted or property owned by it makes such qualification
necessary, except where the failure to be so
qualified or in good standing, as
the case may be, could not, individually or
in the aggregate, have or reasonably
be expected to result in a Material Adverse
Effect.
(c) Authorization;
Enforcement.
The Company has the requisite
corporate power and authority to enter into
and to consummate the
transactions
contemplated by each of the Transaction
Documents and otherwise to carry out its
obligations thereunder. The execution and delivery of each
of the Transaction
Documents by the Company and the consummation by it of the transactions
contemplated thereby have been duly
authorized by all
necessary action on
the
part of the Company and no further action is required by the Company in
connection therewith. Each Transaction Document has been
(or upon delivery will
have been) duly executed by the Company
and, when delivered in
accordance with
the terms hereof, will constitute the valid and binding obligation of the
Company enforceable against the Company in
accordance with its terms, except as
such enforceability may be limited by applicable bankruptcy, insolvency,
reorganization, moratorium, liquidation or similar laws relating to, or
affecting generally the enforcement of, creditors' rights and remedies or by
other equitable principles of general
application.
(d) No Conflicts. The
execution,
delivery and
performance of the
Transaction Documents by the Company and the
consummation by the Company of the
transactions contemplated thereby do not and will not (i) conflict with or
violate any provision of the Company's or any Subsidiary's certificate or
articles of incorporation, bylaws or other organizational or
charter documents,
or (ii) conflict with, or constitute a default (or
an event that with notice or
lapse of time or both would become a default) under, or give to others any
rights of termination, amendment, acceleration or
cancellation (with or without
notice, lapse of time or both) of, any
agreement, credit facility, debt or other
instrument (evidencing a Company or Subsidiary debt or otherwise) or other
understanding to which the Company or any
Subsidiary is a party or by which any
property or asset of the Company or any
Subsidiary
is bound or
affected, or
12
<PAGE>
(iii) result in a violation of any law, rule, regulation, order, judgment,
injunction, decree or other restriction of any
court or governmental
authority
to which the Company or a Subsidiary is subject (including federal and state
securities laws and regulations), or by which any property or asset of the
Company or a Subsidiary is bound or affected; except in the case of each of
clauses (ii) and (iii), such as could not, individually or in the aggregate,
have or reasonably be expected to result in
a Material Adverse Effect. Except as
set forth in Schedule 3.1(d), payments of cash on account of
principal of or
interest under the Notes, upon any Event of
Default under the Notes, as a result
of liquidated damages under any Transaction
Document or upon a
Buy-In under and
as such term is defined in a Warrant will not require the consent of, any
payment to, or the springing of any Lien in favor of any lender
to or creditor
of the Company or any Subsidiary (under a credit facility, loan agreement or
otherwise) and will not result in a default
under any such credit
facilities,
loans or other agreements.
(e) Filings, Consents
and Approvals. The Company is not required to
obtain any consent, waiver, authorization or order of, give any notice to,
or
make any filing or registration
with, any court or
other federal, state,
local
or other governmental authority or other Person in connection with the
execution, delivery and performance by the
Company of the Transaction Documents,
other than (i) the filing with the Commission of one or more Registration
Statements in accordance with the
requirements
Registration Rights
Agreement,
(ii) filings required by state securities laws,
(iii) the filing of a Notice of
Sale of Securities on Form D with the Commission under Regulation D of the
Securities Act (iv) the filings required in accordance with Section 4.7 and
4.10, and (iv) those that have been made
or obtained prior to
the date of this
Agreement.
(f) Issuance
of the Securities. The Securities have been duly
authorized and, when issued and paid for in
accordance
with the Transaction
Documents, will be duly and validly issued,
fully paid and nonassessable, free
and clear of all Liens. The Company has reserved from its duly authorized
capital stock a number of shares of Common
Stock issuable upon conversion of the
Notes and upon exercise of the Warrants,
which number of
reserved shares is not
less than the Required Minimum calculated
as of the date hereof.
(g) Capitalization. The number of shares and type of all
authorized,
issued and outstanding capital stock of the Company,
and all shares of
Common
Stock reserved for issuance under the Company's various option and incentive
plans, is specified in the SEC Reports.
Except as specified in
the SEC Reports,
no securities of the Company are entitled
to preemptive or similar rights, and
no Person has any right of first refusal, preemptive right, right of
participation, or any similar right to participate in the transactions
contemplated by the Transaction Documents. Except as specified in the SEC
Reports, and except in connection with the issuance of Anti-Dilution
Entitlements and New Entitlements (each as
defined in the Amendment), there are
no outstanding options, warrants, scrip rights to subscribe to, calls or
commitments of any character whatsoever relating to, or securities,
rights or
obligations convertible into or
exchangeable for, or giving any Person any right
to subscribe for or acquire, any shares of Common Stock, or contracts,
commitments, understandings or arrangements by which the Company or any
Subsidiary is or may become bound to issue
additional shares of Common Stock, or
securities or rights convertible or exchangeable into shares of Common Stock.
Except in connection with the issuance of Anti-Dilution Entitlements and New
13
<PAGE>
Entitlements, the issue and sale of the
Securities will not, immediately or with
the passage of time, obligate the Company to issue shares of Common Stock or
other securities to any Person (other than
the Investors) and will not result in
a right of any holder of Company securities
to adjust the exercise, conversion,
exchange or reset price under such
securities.
(h) SEC Reports;
Financial Statements. The Company has filed all
reports, forms or other information required to be filed by it under the
Securities Act and the Exchange Act, including pursuant to Section 13(a) or
15(d) thereof, for the twelve months preceding
the date hereof (or such shorter
period as the Company was required by law
to file such reports)
(the foregoing
materials being collectively referred to herein as the "SEC REPORTS" and,
together with the Schedules to this Agreement (if any), the "DISCLOSURE
MATERIALS") on a timely basis or has timely
filed a valid extension of such time
of filing and has filed any such SEC
Reports prior to the expiration of any such
extension. As of their respective dates, the SEC Reports complied in all
material respects with the requirements of the Securities Act
and the Exchange
Act and the rules and regulations of the
Commission promulgated thereunder, and
none of the SEC Reports, when filed, contained any untrue statement of a
material fact or omitted to state a
material fact required to be stated therein
or necessary in order to make the statements therein, in light of the
circumstances under which they were made, not misleading. The financial
statements of the Company included in the SEC Reports
comply in all
material
respects with applicable accounting requirements and the rules and
regulations
of the Commission with respect thereto as
in effect at the time of filing. Such
financial statements have been prepared in accordance with GAAP applied on a
consistent basis during the periods involved, except as may be otherwise
specified in such financial statements or the notes thereto,
and fairly present
in all material respects the financial position of the Company and its
consolidated Subsidiaries as of and for the dates
thereof and the results of
operations and cash flows for the periods
then ended, subject,
in the case of
unaudited statements, to normal, immaterial, year-end audit adjustments.
For
purposes of this Agreement, any reports, forms or other
information provided to
the Commission whether by filing,
furnishing or otherwise providing, is included
in the term "filed" (or any derivations
thereof).
(i)
Press Releases. The
press releases
disseminated by the Company
during the twelve months preceding the date of this
Agreement taken as a
whole
do not contain any untrue statement of a material fact or omit to state a
material fact required to be stated therein or necessary in order to
make the
statements therein, in light of the
circumstances under which they were made and
when made, not misleading.
(j) Material Changes. Since the date of the latest audited
financial
statements included within the SEC Reports,
except as specifically
disclosed in
the SEC Reports, (i) there has been no
event, occurrence or development that has
had or that could reasonably be expected to
result in a Material Adverse Effect,
(ii) the Company has not incurred any liabilities (contingent or otherwise)
other than (A) trade payables, accrued expenses and other
liabilities
incurred
in the ordinary course of business consistent with past practice and (B)
liabilities (not to exceed $50,000) not required to be reflected in the
Company's financial statements pursuant to GAAP or
required to be disclosed in
filings made with the Commission, (iii) the Company has not altered
its method
of accounting or the identity of its
auditors, (iv) the Company has not declared
14
<PAGE>
or made any dividend or distribution of cash or other property to its
stockholders or purchased, redeemed or made
any agreements to purchase or redeem
any shares of its capital stock, and (v) the Company has not issued
any equity
securities to any officer, director or Affiliate,
except pursuant to existing
Company stock option plans and consistent
with past practice.
The Company does
not have pending before the Commission any
request for confidential treatment of
information.
(k) Litigation.
There is no Action
which (i) adversely
affects or
challenges the legality, validity or enforceability of any of the Transaction
Documents or the Securities or (ii) except
as specifically
disclosed in the SEC
Reports, would, if there were an
unfavorable decision,
individually or in
the
aggregate, have or reasonably be expected to result in a Material Adverse
Effect. Neither the Company nor any Subsidiary, nor any director or officer
thereof (in his or her capacity as such), is or has been the subject of any
Action involving a claim of violation of
or liability
under federal or state
securities laws or a claim of breach of
fiduciary duty,
except as
specifically
disclosed in the SEC Reports. There has not been, and to the knowledge of the
Company there is not pending, any investigation by the
Commission involving the
Company or any current or former director or officer of the Company
(in his or
her capacity as such). The Commission has not issued any stop order or
other
order suspending the effectiveness of any registration statement filed by the
Company or any Subsidiary under the
Exchange Act or the Securities Act.
(l) Labor Relations.
No material
labor dispute
exists or, to the
knowledge of the Company, is imminent with respect to any of the
employees of
the Company.
(m) Compliance.
Neither the Company
nor any Subsidiary
(i) is in
default under or in violation of (and no event has occurred
that has not been
waived that, with notice or lapse of time
or both, would result
in a default by
the Company or any Subsidiary under), nor has the Company or any Subsidiary
received notice of a claim that it is in default under or that it is in
violation of, any indenture, loan or credit agreement or any
other agreement or
instrument to which it is a party
or by which it or any
of its properties
is
bound (whether or not such default or
violation has been
waived), (ii) is in
violation of any order of any court,
arbitrator or
governmental body, or
(iii)
is or has been in violation of any statute, rule or regulation of any
governmental authority, including without
limitation all foreign, federal, state
and local laws relating to taxes,
environmental protection, occupational health
and safety, product quality and safety and
employment and labor matters, except
in each case as could not, individually or
in the aggregate, have
or reasonably
be expected to result in a Material Adverse
Effect. The Company is in compliance
with all effective requirements of the Sarbanes-Oxley Act of 2002, as
amended,
and the rules and regulations thereunder, that are applicable to it, except
where such noncompliance could not have or
reasonably be expected to result in a
Material Adverse Effect.
(n) Regulatory Permits. The Company and the Subsidiaries possess
all
certificates, authorizations and permits issued by the appropriate federal,
state, lo